Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum JOHNSON & JOHNSON JNJ

Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company's primary focus is products related to human health and well-being. It operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including... see more

NYSE:JNJ - Post Discussion

JOHNSON & JOHNSON > Point-of-Care Diagnostics Market Size and Share 2021-2026
View:
Post by edwardebreen15 on Aug 22, 2022 8:45am

Point-of-Care Diagnostics Market Size and Share 2021-2026

According to IMARC Group’s latest report, titled “Point-of-Care Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global market reached a strong growth in 2020. Point-of-Care (PoC) diagnostics is a medical assessment, which is extensively deployed in the healthcare industry for facilitating effective disease diagnosis, management, and monitoring. It is also utilized for supplying diagnostic facilities to remote locations. PoC testing includes various portable equipment for urinalysis, glucose monitoring, cardiometabolic, and infectious disease. Currently, PoC diagnostics are commercially available in varying types, such as infectious disease, cardio-metabolic, and blood-glucose test kits.

 

Request for a PDF sample of this report: https://www.imarcgroup.com/point-of-care-diagnostics-market/requestsample

 

The point-of-care diagnostics market is primarily driven by the numerous initiatives undertaken by the governments of various nations for improving the healthcare infrastructure by incorporating various techniques and technologies. Additionally, the widespread adoption of wireless devices for enabling the direct transmission of patient data is contributing to market growth. Apart from this, rising consumer consciousness regarding the early detection of diseases and the increasing prevalence of various infectious and chronic diseases, such as cancer, hepatitis, and cardiac diseases, are creating a positive outlook for the market. Looking forward, IMARC Group expects the global point-of-care diagnostics market to continue its robust growth during the forecast period (2021-2026).

 

Checkout Now: https://www.imarcgroup.com/checkout?id=2113&method=1

 

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

 

Competitive Landscape with Key Players:

  • Abbott Laboratories
  • Beckman Coulter Inc.
  • Becton Dickinson and Company
  • Hoffmann-La Roche AG
  • Instrumentation Laboratory
  • Johnson & Johnson
  • Nova Biomedical Corporation
  • Pts Diagnostics
  • Qiagen
  • Siemens
  • Trinity Biotech

Breakup by Product Type:

  • Blood-Glucose Monitoring Kit
  • Cardio-Metabolic Monitoring Kit
  • Pregnancy and Fertility Testing Kit
  • Infectious Disease Testing Kit
  • Cholesterol Test Strip
  • Hematology Testing Kit
  • Others

Market Segmentation:

 

Breakup by Platform:

  • Lateral Flow Assays
  • Dipsticks
  • Microfluidics
  • Molecular Diagnostics
  • Immunoassays

Breakup by Prescription Mode:

  • Prescription-Based Testing
  • OTC Testing

Breakup by End-User:

  • Professional Diagnostic Centers
  • Home Care
  • Research Laboratories
  • Others

Breakup by Region:

  • North America (United States, Canada)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)

Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/point-of-care-diagnostics-market

 

Note: We are updating our reports, If you want the report with the latest primary and secondary data (2021-2026) including industry trends, market size and Competitive landscape, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.

 

Key highlights of the report:                                                    

  • Market Performance (2015-2020)
  • Market Outlook (2021-2026)
  • Market Trends
  • Market Drivers and Success Factors
  • Impact of COVID-19
  • Value Chain Analysis
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

 

Related Reports by IMARC Group:

Organic and Natural Pet Food Market: https://www.imarcgroup.com/organic-natural-pet-food-market

Angioplasty Balloons Market: https://www.imarcgroup.com/angioplasty-balloons-market

Minimally Invasive Surgery Market: https://www.imarcgroup.com/minimally-invasive-surgery-market

Dental Implants Market: https://www.imarcgroup.com/dental-implants-market

Healthcare It Market: https://www.imarcgroup.com/healthcare-it-market

 

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

 

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

 

Contact Us:

IMARC Group

30 N Gould St Ste R

Sheridan, WY 82801 USA - Wyoming

Email: Sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

Americas: - +1 631 791 1145 | Africa and Europe: - +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities